These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8225689)

  • 1. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.
    Keller-Stanislawski B; Caspary S; Merz PG; Bonn R; Wolff M; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):417-21. PubMed ID: 8225689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nicotine and cotinine after application of two different nicotine patches under steady state conditions.
    Keller-Stanislawski B; Caspary S
    Arzneimittelforschung; 1992 Sep; 42(9):1160-2. PubMed ID: 1445487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.
    Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI
    Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions.
    Caspary S; Keller-Stanislawski B; Huber T; Merz PG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):92-5. PubMed ID: 2071260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine patch therapy in adolescent smokers.
    Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
    Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk.
    Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP
    Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
    Kochak GM; Sun JX; Choi RL; Piraino AJ
    Pharm Res; 1992 Nov; 9(11):1451-5. PubMed ID: 1475232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems.
    Gries JM; Benowitz N; Verotta D
    J Pharmacol Exp Ther; 1998 May; 285(2):457-63. PubMed ID: 9580583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers.
    Feng S; Kapur S; Sarkar M; Muhammad R; Mendes P; Newland K; Roethig HJ
    Toxicol Lett; 2007 Sep; 173(2):101-6. PubMed ID: 17716838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient C-oxidation of nicotine.
    Benowitz NL; Jacob P; Sachs DP
    Clin Pharmacol Ther; 1995 May; 57(5):590-4. PubMed ID: 7768082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
    Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
    Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.